Literature DB >> 11694018

Modification of crystal habit and its role in dosage form performance.

A K Tiwary1.   

Abstract

Crystallization is often employed for purifying a drug substance. Use of different solvents and processing conditions may change the crystal habit, besides altering the polymorphic state. Furthermore, altered habit may result from crystal growth during storage. Hence, there is a need to understand the factors influencing crystal habit and to evaluate critically, its role in the performance of dosage forms. Establishing the physicotechnical properties of different habits of a drug will help to recognize lot-to-lot variations in raw materials and to ensure reproducibility of dosage form performance.

Mesh:

Substances:

Year:  2001        PMID: 11694018     DOI: 10.1081/ddc-100107327

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  7 in total

Review 1.  Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration.

Authors:  Maryam Maghsoodi
Journal:  Adv Pharm Bull       Date:  2015-03-05

2.  Solid-state characterization of nevirapine.

Authors:  Mahua Sarkar; O P Perumal; R Panchagnula
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

3.  Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.

Authors:  Maryam Maghsoodi; Farhad Kiafar
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

4.  Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.

Authors:  Maryam Maghsoodi; Farhad Kiafar
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

5.  Complex Growth of Benzamide Form I: Effect of Additives, Solution Flow, and Surface Rugosity.

Authors:  Caroline A Offiler; Cláudio P Fonte; Weronika Kras; Petros Neoptolemou; Roger J Davey; Thomas Vetter; Aurora J Cruz-Cabeza
Journal:  Cryst Growth Des       Date:  2022-09-27       Impact factor: 4.010

6.  Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.

Authors:  Kevin Garala; Jaydeep Patel; Anjali Patel; Mihir Raval; Abhay Dharamsi
Journal:  Int J Pharm Investig       Date:  2012-10

7.  Preparation and crystallographic analysis of gliclazide polymorphs.

Authors:  A J Rajamma; S B Sateesha; M K Narode; V R S S Prashanth; A M Karthik
Journal:  Indian J Pharm Sci       Date:  2015 Jan-Feb       Impact factor: 0.975

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.